Skip to content

Executive Function Play Opportunities for Children With Down Syndrome

Executive Function Intervention for Young Children With Down Syndrome

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07792382
Acronym
EXPO
Enrollment
150
Registered
2026-08-28
Start date
2026-09-01
Completion date
2029-11-30
Last updated
2026-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Down Syndrome, Trisomy 21

Keywords

executive function, parent-implemented, play based, preschooler, early childhood, developmental

Brief summary

The Executive Function Play Opportunities (EXPO) study is a sequential, multiple assignment, randomized trial (SMART) evaluating adaptive caregiver-mediated intervention pathways for improving executive function (EF) in children with Down syndrome (DS). At baseline, participants will be randomized in a 1:4 ratio to receive either a delayed-treatment control condition or the EXPO intervention. After 4 weeks of standard EXPO intervention in stage 1, participants in the EXPO condition will be assessed for response to the intervention based on prespecified criteria for improvement in laboratory-based EF performance. Early responders will continue with the standard EXPO intervention in stage 2. Slower responders will be randomized to either the EXPO Extended or EXPO Foundations pathway. All participants will complete laboratory and parent-report measures of EF immediately post-intervention and 3 months later. Participants in the delayed-treatment control condition will complete the same assessments as the EXPO groups and will be offered the EXPO intervention after completion of the 3-month follow-up.

Detailed description

The Executive Function Play Opportunities (EXPO) study is a sequential, multiple assignment, randomized trial (SMART) evaluating adaptive caregiver-mediated intervention pathways for improving executive function (EF) in children with Down syndrome (DS). At baseline, all participants will complete an assessment including laboratory-based measures of EF, parent-report measures of EF, and intensive ecological measurement of EF using the iBehavior app. Participants will then be randomized in a 1:4 ratio to receive either a delayed-treatment control condition or the EXPO intervention, with a target total sample size of 150. During stage 1, participants in the EXPO condition will complete 4 weeks of standard EXPO intervention. The initial weeks of EXPO consist of 2 weeks of EXPO Ready activities followed by 2 weeks of Working Memory activities, and all participants in the EXPO intervention receive ongoing support from an EXPO coach. At the stage 1 evaluation, conducted 4 weeks after starting EXPO, all participants will complete the laboratory-based EF assessment battery. EXPO participants will be assessed for response to the intervention and classified as early or slower responders based on prespecified criteria for improvement in laboratory-based EF performance. Early responders will be assigned to the standard EXPO intervention in stage 2 and continue with activities targeting inhibition, cognitive flexibility, planning, and consolidation of skills for a total of 12 weeks. Slower responders will be randomly assigned in a 1:1 ratio to either the EXPO Extended or EXPO Foundations pathway. The EXPO Extended pathway will include the same core activities as the EXPO standard pathway but will provide additional intervention time, for a total of 18 weeks. The EXPO Foundations pathway will begin with a block of activities targeting early social communication and regulation to provide a foundation for activity engagement, followed by more foundational versions of activities targeting inhibition and cognitive flexibility. The EXPO Foundations pathway will continue for a total of 12 weeks. All participants will complete laboratory and parent-report measures of EF immediately post-intervention and 3 months later. Participants in the delayed-treatment control condition will not receive EXPO during the initial study period but will complete the same assessments as participants in the EXPO intervention. Following completion of the 3-month follow-up, participants in the delayed-treatment control condition will be offered the EXPO intervention.

Interventions

BEHAVIORALEXPO

EXPO is a novel intervention that targets the development of EF through play-based opportunities for children with DS and their primary caregivers. EXPO is a 'syndrome-informed' intervention in that all activities are tailored to phenotypic strengths and challenges associated with DS, accounting for cognitive, language, and motor presentations frequently observed in this population. EXPO is also designed to elicit maximal engagement and enjoyment for children and their caregivers by embedding opportunities to strengthen EF component processes in the context of play and games.

BEHAVIORALEXPO Extended

Alternative EXPO pathway that extends the length of the EXPO intervention from 12 to 18 weeks to provide more time and opportunity for skill acquisition.

BEHAVIORALEXPO Foundations

An augmented version of EXPO that places a greater emphasis on precursors to EXPO activity engagement, including an increased number of social routine activities, enhanced presses for social communication behaviors like joint attention, enhanced focus on early self-regulation skills, and adaptations of all EXPO activities in each block that emphasize more foundational aspects of play.

Sponsors

Colorado State University
Lead SponsorOTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
University of Padova
CollaboratorOTHER
University of California, Los Angeles
CollaboratorOTHER
University of Southern California
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Single: Outcomes Assessors naive to coaching information; Coaches naive to examiner-collected outcome assessment (including direct assessment measures and proxy-report measures)

Intervention model description

Sequential, Multiple Assignment, Randomized Trial (SMART)

Eligibility

Sex/Gender
ALL
Age
36 Months to 72 Months
Healthy volunteers
No

Inclusion criteria

* confirmed medical diagnosis of Down syndrome

Exclusion criteria

* no complete hearing or vision loss * primary exposure to English or Italian

Design outcomes

Primary

MeasureTime frameDescription
Adapted Reverse CategorizationFrom enrollment to the end of treatment, with a 3-month follow-upRule switch task that involves sorting by color, and then reversing the sort rule
Zoo Animal SwitchFrom enrollment to the end of treatment, with a 3-month follow-upRule switch task that involves sorting large and small animal pairs by size into large and small buckets, then reversing the rule to put large animals into the small bucket, and small animals into the large bucket
Developmental Profiles-4 Cognitive domainFrom enrollment to the end of treatment, with a 3-month follow-upGrowth Scale Values in the Developmental Profiles-4 Cognitive domain
Developmental Profiles-4 Social-emotional domainFrom enrollment to the end of treatment, with a 3-month follow-upGrowth Scale Values in the Developemental Profiles-4 Social-Emotional domain

Secondary

MeasureTime frameDescription
iBehavior Ecological Momentary AssessmentFrom enrollment to the end of treatment, with a 3-month follow-up
Self ordered pointing: Garage GameFrom enrollment to the end of treatment, with a 3-month follow-upSelf-ordered pointing task that requires working memory/updating
BRIEF-Preschool Inhibition DomainFrom enrollment to the end of treatment, with a 3-month follow-upStandardized Caregiver Report of Executive Functioning for Preschool aged children
Hearts and FlowersFrom enrollment to the end of treatment, with a 3-month follow-upOpposites task that involves matching cards to the opposite type of card
Developmental Profiles-4 Adaptive Behavior domainFrom enrollment to the end of treatment, with a 3-month follow-upGrowth Scale Values in the Developmental Profiles-4 Adaptive Behavior domain
Building TaskFrom enrollment to the end of treatment, with a 3-month follow-upShape design task that involves reproducing a pattern of blocks according to a design produced by the examiner

Countries

Italy, United States

Contacts

CONTACTKaylyn Van Deusen, MS
kaylyn.van_deusen@colostate.edu9704911969
CONTACTMiranda Pinks, MS
miranda.pinks@colostate.edu970-4911969
PRINCIPAL_INVESTIGATORDeborah Fidler

Colorado State University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 29, 2026